{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:01:49Z","timestamp":1793934109107,"version":"4.8.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008320.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000}}],"reference-count":300,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008320.pub4","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T08:53:01Z","timestamp":1684140781000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacological interventions for pruritus in adult palliative care patients"],"prefix":"10.1002","volume":"2024","author":[{"given":"Christopher","family":"Boehlke","sequence":"additional","affiliation":[{"name":"Department of Palliative Care; University Hospital; Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Joos","sequence":"additional","affiliation":[{"name":"Department of Palliative Care, Medical Center - University of Freiburg; Faculty of Medicine, University of Freiburg; Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Coune","sequence":"additional","affiliation":[{"name":"Department of Palliative Care, Medical Center - University of Freiburg; Faculty of Medicine, University of Freiburg; Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Becker","sequence":"additional","affiliation":[{"name":"Department of Palliative Care, Medical Center - University of Freiburg; Faculty of Medicine, University of Freiburg; Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg J","family":"Meerpohl","sequence":"additional","affiliation":[{"name":"Institute for Evidence in Medicine; Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg; Freiburg Germany"},{"name":"Cochrane Germany; Cochrane Germany Foundation; Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Buroh","sequence":"additional","affiliation":[{"name":"Library of the Center of Surgery; University Medical Center; Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hercz","sequence":"additional","affiliation":[{"name":"Jackson Memorial Hospital \/ University of Miami; Miami FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Schwarzer","sequence":"additional","affiliation":[{"name":"Institute of Medical Biometry and Statistics; Faculty of Medicine and Medical Center, University of Freiburg; Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhild","family":"Becker","sequence":"additional","affiliation":[{"name":"Department of Palliative Care, Medical Center - University of Freiburg; Faculty of Medicine, University of Freiburg; Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.12669\/pjms.321.8547","article-title":"Comparison of gabapentin and ketotifen in treatment of uremic pruritus in hemodialysis patients","volume":"32","author":"Amirkhanlou","year":"2016","journal-title":"Pakistan Journal of Medical Sciences"},{"issue":"8","key":"10.1002\/14651858.CD008320.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/ijd.14953","article-title":"A randomized controlled study of 6% gabapentin topical formulation for chronic kidney disease-associated pruritus","volume":"59","author":"Aquino","year":"2020","journal-title":"International Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/s0272-6386(00)70251-4","article-title":"Ondansetron therapy for uremic pruritus in hemodialysis patients","volume":"35","author":"Ashmore","year":"2000","journal-title":"American Journal of Kidney Diseases"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2174\/157488711466619032813072","article-title":"Comparison of sertraline with rifampin in the treatment of cholestatic pruritus: a randomized clinical trial","volume":"13","author":"Ataei","year":"2019","journal-title":"Reviews on Recent Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3109\/08860228009065337","article-title":"Dialysis pruritus: effect of cimetidine","volume":"4","author":"Aubia","year":"1980","journal-title":"Journal of Dialysis"},{"issue":"8638","key":"10.1002\/14651858.CD008320.pub4-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/s0140-6736(89)91608-5","article-title":"Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis","volume":"1","author":"Bachs","year":"1989","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1051-2276(04)00134-7","article-title":"Supplementation with n-3 and n-6 polyunsaturated fatty acids: effects on lipoxygenase activity and clinical symptoms of pruritus in hemodialysis patients","volume":"14","author":"Begum","year":"2004","journal-title":"Journal of Renal Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21370","article-title":"Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial","volume":"44","author":"Bergasa","year":"2006","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0009|cit9","first-page":"787A","article-title":"Nalfurafine (TRK-820) as a treatment for uremic pruritus (UP): patients are responsive independent of baseline itch - data from a multicenter, randomized, placebo controlled trial [abstractno: SA-PO1014]","volume":"17","author":"Bhaduri","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0016-5085(93)90858-a","article-title":"Subhypnotic doses of propofol relieve pruritus associated with liver disease","volume":"104","author":"Borgeat","year":"1993","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0190-9622(92)70013-6","article-title":"Topical capsaicin for treatment of hemodialysis-related pruritus","volume":"26","author":"Breneman","year":"1992","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/s0190-9622(97)70240-8","article-title":"Uremic pruritus: roles of parathyroid hormone and substance P","volume":"36","author":"Cho","year":"1997","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD008320.pub4-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"SP150","DOI":"10.1093\/ndt\/gfz103.SP150","article-title":"Efficacy of desloratadine versus bilastine on uremic pruritus in patients with end stage renal disease","volume":"34","author":"Chourdakis","year":"2019","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"15","key":"10.1002\/14651858.CD008320.pub4-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1056\/NEJM199204093261501","article-title":"Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia","volume":"326","author":"De Marchi","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"6436","key":"10.1002\/14651858.CD008320.pub4-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/bmj.289.6436.22","article-title":"Treatment of pruritus due to chronic obstructive liver disease","volume":"289","author":"Duncan","year":"1984","journal-title":"British Medical Journal (Clinical Research Edition)"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jaad.2004.08.05","article-title":"Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study","volume":"52","author":"Duque","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD008320.pub4-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"510","DOI":"10.5414\/cp201629","article-title":"Efficacy of topical cromolyn sodium 4% on pruritus of uremic nephrogenic patients: a randomized double blind study on 60 patients","volume":"50","author":"Feily","year":"2012","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1056\/NEJMoa1912770","article-title":"A phase 3 trial of difelikefalin in hemodialysis patients with pruritus","volume":"382","author":"Fishbane","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ekir.2020.01.006","article-title":"Randomized controlled trial of difelikefalin for chronic pruritus in hemodialysis patients","volume":"5","author":"Fishbane","year":"2020","journal-title":"Kidney International Reports"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD008320.pub4-BIB0020|cit20","first-page":"80","article-title":"Randomized, placebo-controlled study on the efficacy of CR845 in improving the quality of life of hemodialysis patients with CKD-associated pruritus [abstract no: SA-OR032]","volume":"28","author":"Menzaghi","year":"2017","journal-title":"American Society of Nephrology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD008320.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/j.jid.2018.03.591","article-title":"Psychometric validation and meaningful change threshold of the worst itching intensity numerical rating scale for use in hemodialysis patients with pruritus [abstract]","volume":"138","author":"Munera","year":"2018","journal-title":"Journal of Investigative Dermatology"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD008320.pub4-BIB0022|cit22","first-page":"629","article-title":"Randomized, placebo-controlled study on the efficacy of CR845 in reducing CKD-associated pruritus in hemodialysis patients [abstract no: FR-PO875]","volume":"28","author":"Spencer","year":"2017","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1053\/j.ajkd.2018.02.286","article-title":"Clinically meaningful itch reduction by CR845: an 8-week randomized, placebo-controlled study in hemodialysis patients [abstract no: 280]","volume":"71","author":"Spencer","year":"2018","journal-title":"American Journal of Kidney Diseases"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/hdi.13007","article-title":"Pruritus-reducing effects of omega-3 fatty acids in hemodialysis patients: a cross-over randomized clinical trial","volume":"26","author":"Forouhari","year":"2022","journal-title":"Hemodialysis International"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/hdi.12455","article-title":"Comparison of pregabalin with doxepin in the management of uremic pruritus: a randomized single blind clinical trial","volume":"21","author":"Foroutan","year":"2017","journal-title":"Hemodialysis International"},{"issue":"9","key":"10.1002\/14651858.CD008320.pub4-BIB0026|cit26","first-page":"515\u201322","article-title":"Efficacy of omega-3 fatty acids supplementation in treatment of uremic pruritus in hemodialysis patients: a double-blind randomized controlled trial","volume":"14","author":"Ghanei","year":"2012","journal-title":"Iranian Red Crescent Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0016-5085(88)90442-8","article-title":"Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial","volume":"94","author":"Ghent","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s11255-020-02473-3","article-title":"Effect of mirtazapine on pruritus in patients on hemodialysis: a cross\u2011over pilot study","volume":"52","author":"Gholyaf","year":"2020","journal-title":"International Urology and Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2310\/6620.2011.10110","article-title":"Lack of efficacy of topical calcineurin inhibitor pimecrolimus 1% on pruritus of severely uremic patients: a randomized double-blind study in 60 patients","volume":"22","author":"Ghorbani","year":"2012","journal-title":"Dermatitis"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0030|cit30","first-page":"11","article-title":"A comparison between the effect of cromolyn sodium gel 4% and pimecrolimus cream 1% in treatment of pruritus of patients with end stage renal disease","volume":"19","author":"Ghorbani Birgani","year":"2011","journal-title":"Avicenna Journal of Nursing & Midwifery Care"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1684\/ejd.2018.3356","article-title":"Gabapentin versus dexchlorpheniramine as treatment for uremic pruritus: a randomised controlled trial","volume":"28","author":"Gobo-Oliveira","year":"2018","journal-title":"European Journal of Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD008320.pub4-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1093\/ndt\/gfh496","article-title":"Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial","volume":"19","author":"Gunal","year":"2004","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/ced.14270","article-title":"Comparison of gabapentin and hydroxyzine in the treatment of pruritus in patients on dialysis","volume":"45","author":"Kebar","year":"2020","journal-title":"Clinical and Experimental Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/hep.23821","article-title":"The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial","volume":"52","author":"Kuiper","year":"2010","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/hepr.1283","article-title":"Efficacy of nalfurafine hydrochloride in patients with chronic liver disease with refractory pruritus: a randomized, double-blind trial","volume":"47","author":"Kumada","year":"2017","journal-title":"Hepatology Research"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/ndt\/gfp588","article-title":"Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a phase III, randomized, double-blind, placebo-controlled study","volume":"25","author":"Kumagai","year":"2010","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/jrpp.JRPP_18_64","article-title":"Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: a crossover randomized pilot clinical trial","volume":"7","author":"Lahiji","year":"2018","journal-title":"Journal of Research in Pharmacy Practice"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1159\/000077841","article-title":"A comparative study on the effects of naltrexone and loratadine on uremic pruritus","volume":"208","author":"Legroux-Crespel","year":"2004","journal-title":"Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0039|cit39","first-page":"50","article-title":"Therapeutic effect of montelukast for treatment of uremic pruritus in hemodialysis patients","volume":"11","author":"Mahmudpour","year":"2017","journal-title":"Iranian Journal of Kidney Diseases"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0040|cit40","first-page":"137","article-title":"Topical capsaicin therapy for uremic pruritus in patients on hemodialysis","volume":"4","author":"Makhlough","year":"2010","journal-title":"Iranian Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0041|cit41","first-page":"351","article-title":"Comparison of the efficacy and safety of zinc sulfate vs. placebo in the treatment of pruritus of hemodialytic patients: a pilot randomized, triple-blind study","volume":"150","author":"Mapar","year":"2015","journal-title":"Giornale Italiano di Dermatologia e Venereologia [Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases]"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD008320.pub4-BIB0042|cit42","first-page":"841A","article-title":"Gabapentin therapy for pruritus in automated peritoneal dialysis patients: a randomized controlled trial","volume":"24","author":"Marin","year":"2013","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1159\/000484573","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of nalbuphine ER tablets for uremic pruritus","volume":"46","author":"Mathur","year":"2017","journal-title":"American Journal of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/hep.21553","article-title":"Sertraline as a first-line treatment for cholestatic pruritus","volume":"45","author":"Mayo","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/hep4.1305","article-title":"A randomized, controlled, phase 2 study of maralixibat in the treatment of itching associated with primary biliary cholangitis","volume":"3","author":"Mayo","year":"2019","journal-title":"Hepatology Communications"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0046|cit46","first-page":"80","article-title":"Effect of ondansetron on pruritus in hemodialysis patients","volume":"16","author":"Mirnezami","year":"2013","journal-title":"Arak Medical University Journal\u00a0"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008320.pub4-BIB0047|cit47","first-page":"ii511","article-title":"Sodium thiosulfate (STS): a new option for hemodialysis patients with uremic pruritus [abstract no: SAP598]","volume":"27","author":"Mohamed","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008320.pub4-BIB0048|cit48","first-page":"7","article-title":"Pruritus-reducing effects of omega-3 fatty acids in hemodialysis patients [abstract no: P106]","volume":"11","author":"Mortazavi","year":"2017","journal-title":"Iranian Journal of Kidney Diseases"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1365-2133.2003.05172.x","article-title":"A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch","volume":"148","author":"Murphy","year":"2003","journal-title":"British Journal of Dermatology"},{"issue":"Suppl6","key":"10.1002\/14651858.CD008320.pub4-BIB0050|cit50","first-page":"vi181","article-title":"The effect of gabapentin on uremic pruritus in hemodialysis patients [abstract no: FP479]","volume":"22","author":"Naghibi","year":"2007","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0051|cit51","first-page":"378","article-title":"Gabapentin: a promising drug for the treatment of uremic pruritus","volume":"18","author":"Naini","year":"2007","journal-title":"Saudi Journal of Kidney Diseases and Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1744-9987.2011.01032.x","article-title":"Zinc sulfate for relief of pruritus in patients on maintenance hemodialysis","volume":"16","author":"Najafabadi","year":"2012","journal-title":"Therapeutic Apheresis & Dialysis"},{"issue":"0","key":"10.1002\/14651858.CD008320.pub4-BIB0053|cit53","first-page":"50","article-title":"Efficacy of pregabalin in uremic pruritus","volume":"13","author":"Najmeh","year":"2019","journal-title":"Iranian Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0054|cit54","first-page":"316","article-title":"Comparison of Avena sativa, vinegar, and hydroxyzine for uremic pruritus of hemodialysis patients: a crossover randomized clinical trial","volume":"9","author":"Nakhaee","year":"2015","journal-title":"Iranian Journal of Kidney Diseases"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0055|cit55","first-page":"73","article-title":"Montelukast for treatment of refractory pruritus in patients on hemodialysis","volume":"1","author":"Nasrollahi","year":"2007","journal-title":"Iranian Journal of Kidney Diseases"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3109\/09546634.2016.1161161","article-title":"Gabapentin: a promising therapy for uremic pruritus in hemodialysis patients: a randomized-controlled trial and review of literature","volume":"27","author":"Nofal","year":"2016","journal-title":"Journal of Dermatological Treatment"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008320.pub4-BIB0057|cit57","first-page":"27","article-title":"Comparison of gabapentin and antihistamins in treatment of uremic pruritus and its psychological problems [abstract no: P209]","volume":"5","author":"Noshad","year":"2011","journal-title":"Iranian Journal of Kidney Diseases"},{"issue":"8","key":"10.1002\/14651858.CD008320.pub4-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/j.1365-2036.2005.02430.x","article-title":"A controlled trial of ondansetron in the pruritus of cholestasis","volume":"21","author":"O'Donohue","year":"2005","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"995","DOI":"10.4103\/1319-2442.118070","article-title":"Therapeutic effect of oral nicotinamide on refractory uremic pruritus: a randomized, double-blind study","volume":"24","author":"Omidian","year":"2013","journal-title":"Saudi Journal of Kidney Diseases and Transplantation"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0060|cit60","first-page":"130","article-title":"Comparison of ondansetron and cyproheptadine in treatment of uremic pruritus","volume":"35","author":"\u00d6zaykan","year":"2001","journal-title":"T\u00fcrkderm"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/hdi.12540","article-title":"Sertraline can reduce uremic pruritus in hemodialysis patient: a double blind randomized clinical trial from Southern Iran","volume":"22","author":"Pakfetrat","year":"2018","journal-title":"Hemodialysis International"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1681\/ASN.V113514","article-title":"Naltrexone does not relieve uremic pruritus: results of a randomized, double blind, placebo-controlled crossover study","volume":"11","author":"Pauli-Magnus","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"446","DOI":"10.7326\/0003-4819-93-3-446","article-title":"Relief of idiopathic generalized pruritus in dialysis patients treated with activated oral charcoal","volume":"93","author":"Pederson","year":"1980","journal-title":"Annals of Internal Medicine"},{"issue":"9041","key":"10.1002\/14651858.CD008320.pub4-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/s0140-6736(96)04176-1","article-title":"Randomized crossover trial of naltrexone in uraemic pruritus","volume":"348","author":"Peer","year":"1996","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/BF01300759","article-title":"Treatment of pruritus of primary biliary cirrhosis with rifampin","volume":"36","author":"Podesta","year":"1991","journal-title":"Digestive Diseases and Sciences"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0066|cit66","first-page":"34","article-title":"Low-dose doxepin for treatment of pruritus in patients on hemodialysis","volume":"1","author":"Pour-Reza-Gholi","year":"2007","journal-title":"Iranian Journal of Kidney Diseases"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4103\/IJPC.IJPC_212_19","article-title":"Comparison of safety and efficacy of pregabalin versus gabapentin for the treatment of uremic pruritus in patients with chronic kidney disease on maintenance haemodialysis","volume":"26","author":"Ravindran","year":"2020","journal-title":"Indian Journal of Palliative Care"},{"issue":"44","key":"10.1002\/14651858.CD008320.pub4-BIB0068|cit68","first-page":"2704","article-title":"Favorable effect of nicergoline on pruritus in chronic hemodialysis patients. Role of a hyper-alphaadrenergicsystem?\u00a0","volume":"13","author":"Rivory","year":"1984","journal-title":"Presse Medicale"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s11739-019-02175-4","article-title":"Randomized trial of two after\u2011dialysis gabapentin regimens for severe uremic pruritus in hemodialysis patients","volume":"14","author":"Rossi","year":"2019","journal-title":"Internal and Emergency Medicine"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0070|cit70","first-page":"1","article-title":"The effect of the omega-3 supplement on uremic pruritus in hemodialysis patients; a double-blind randomized controlled clinical trial","volume":"8","author":"Shayanpour","year":"2019","journal-title":"Journal of Nephropathology"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1053\/j.jrn.2012.12.007","article-title":"The effect of ergocalciferol on uremic pruritus severity: a randomized controlled trial","volume":"23","author":"Shirazian","year":"2013","journal-title":"Journal of Renal Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000187978","article-title":"Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial","volume":"67","author":"Silva","year":"1994","journal-title":"Nephron"},{"issue":"6063","key":"10.1002\/14651858.CD008320.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/bmj.1.6063.752","article-title":"Cholestyramine in uraemic pruritus","volume":"1","author":"Silverberg","year":"1977","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0074|cit74","unstructured":"Sja'bani M Asdie AH Effect of erythropoietin on pruritus, anemia and quality of life, in chronic hemodialyzed end stage renal disease patients [abstract] ISN XIII International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain 1995 501"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008320.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1016\/S0895-4356(97)87190-9","article-title":"Effect of erythropoietin on pruritus and quality of life in chronic hemodialyzed end stage renal disease patients [abstract]","volume":"50","author":"Sja'bani","year":"1997","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000245987","article-title":"Pruritus in HIV-1 disease: therapy with drugs which may modulate the pattern of immune dysregulation","volume":"195","author":"Smith","year":"1997","journal-title":"Dermatology"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/j.1440-1797.2012.01655.","article-title":"Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study","volume":"17","author":"Solak","year":"2012","journal-title":"Nephrology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008320.pub4-BIB0078|cit78","first-page":"p52","article-title":"Efficacy and safety of oral zinc sulfate for uremic pruritus in ESRD patients: a double-blind, randomized controlled trial","volume":"26","author":"Somkearti","year":"2021","journal-title":"Nephrology"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD008320.pub4-BIB0079|cit79","first-page":"338A","article-title":"Improvement of quality of life in hemodialysis patients with uremic pruritus as measured by the skindex-10 questionnaire: effect of a novel kappa opiod receptor agonist, CR845 [abstract no: TH-PO1040]","volume":"27","author":"Mathur","year":"2016","journal-title":"Journal of the American Societyof Nephrology"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD008320.pub4-BIB0080|cit80","first-page":"B9","article-title":"CR845, a novel kappa opiod receptor agonist reduces moderate-to-severe pruritus and improves quality of life in chronic kidney disease patients undergoing hemodialysis [abstract no: SA-PO1117]","volume":"26","author":"Spencer","year":"2015","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD008320.pub4-BIB0081|cit81","first-page":"348A","article-title":"Ondansetron versus diphenhydramine versus placebo for hemodialysis associated itching [abstract no: A1790]","volume":"12","author":"Subach","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD008320.pub4-BIB0082|cit82","first-page":"300A","article-title":"Effects of gabanpentin and loratadine on uremic pruritus in hemodialysis patients: a randomized controlled trial [abstract no: F-PO896]","volume":"18","author":"Suwanpidokkul","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1056\/NEJM197702032960508","article-title":"Pruritus in dialysis patients treated with parenteral lidocaine","volume":"296","author":"Tapia","year":"1977","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0084|cit84","first-page":"527","article-title":"Treatment of pruritus in dialysis patients with parenteral lidocaine [abstract]","volume":"10","author":"Tapia","year":"1976","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1159\/000188949","article-title":"Hemodialysis-related pruritus: a double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream","volume":"72","author":"Tarng","year":"1996","journal-title":"Nephron"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/s0168-8278(02)00318-5","article-title":"Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis: a crossover, double blind, placebo-controlled study","volume":"37","author":"Terg","year":"2002","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0087|cit87","first-page":"1","article-title":"The effects of gabapentin therapy on pruritus, quality of life, depression and sleep quality in pruritic hemodialysis patients","volume":"27","author":"Tol","year":"2010","journal-title":"Trakya Universitesi Tip Fakultesi Dergisi"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1365-2036.1994.tb00297.x","article-title":"Flumecinol for the treatment of pruritus associated with primary biliary cirrhosis","volume":"8","author":"Turner","year":"1994","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1365-2036.1994.tb00297.x","article-title":"Flumecinol for the treatment of pruritus associated with primary biliary cirrhosis","volume":"8","author":"Turner","year":"1994","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6117","key":"10.1002\/14651858.CD008320.pub4-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/bmj.1.6117.918-c","article-title":"Is cholestyramine helpful in uraemic pruritus?","volume":"1","author":"Van Leusen","year":"1978","journal-title":"British Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/ndt\/gfp628","article-title":"Effect of oral cromolyn sodium on CKD-associated pruritus and serum tryptase level: a double-blind placebo-controlled study","volume":"25","author":"Vessal","year":"2010","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD008320.pub4-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.amjmed.2005.05.031","article-title":"Efficacy of lidocaine in the treatment of pruritus in patients with chronic cholestatic liver diseases","volume":"118","author":"Villamil","year":"2005","journal-title":"American Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD008320.pub4-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1681\/ASN.200502015","article-title":"Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies","volume":"16","author":"Wikstr\u00f6m","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"12","key":"10.1002\/14651858.CD008320.pub4-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1681\/ASN.2005020152","article-title":"Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies","volume":"16","author":"Wikstr\u00f6m","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/gast.1997.v113.pm9322521","article-title":"Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study","volume":"113","author":"Wolfhagen","year":"1997","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/09546630802441218","article-title":"A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients","volume":"20","author":"Young","year":"2009","journal-title":"Journal of Dermatological Treatment"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11255-014-0795-x","article-title":"Comparison of pregabalin with ondansetron in treatment of uraemic pruritus in dialysis patients: a prospective, randomized, double-blind study","volume":"47","author":"Yue","year":"2015","journal-title":"International Urology and Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jpainsymman.2003.05.004","article-title":"Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial","volume":"26","author":"Zylicz","year":"2003","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"e34695","DOI":"10.5812\/ircmj.34695","article-title":"Efficacy of topical application of sweet almond oil on reducing uremic pruritus in hemodialysis patients: a randomized clinical trial study","volume":"19","author":"Afrasiabifar","year":"2016","journal-title":"Iranian Red Crescent Medical Journal"},{"issue":"12","key":"10.1002\/14651858.CD008320.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1046\/j.1365-2036.2000.00869.x","article-title":"Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis","volume":"14","author":"Almasio","year":"2000","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.13005\/bpj\/2025","article-title":"Comparison between moisturizing cream containing 10% urea and 10% lanolin in petrolatum in skin hydration improvement among elderly","volume":"13","author":"Anggraini","year":"2020","journal-title":"Biomedical & Pharmacology Journal"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1755-6686.2010.00190.x","article-title":"The use of pregabalin in the treatment of uraemic pruritus in haemodialysis patients","volume":"36","author":"Aperis","year":"2010","journal-title":"Journal of Renal Care"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1471-2369-13-119","article-title":"Sericin cream reduces pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled experimental study","volume":"13","author":"Aramwit","year":"2012","journal-title":"BMC Nephrology"},{"issue":"6208","key":"10.1002\/14651858.CD008320.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/bmj.280.6208.151","article-title":"Cimetidine for pruritus in Hodgkin's disease","volume":"280","author":"Aymard","year":"1980","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000044967","article-title":"Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients","volume":"78","author":"Balaskas","year":"1998","journal-title":"Nephron"},{"issue":"10","key":"10.1002\/14651858.CD008320.pub4-BIB0106|cit106","first-page":"1404","article-title":"Management of the pruritus of cholestasis: potential role of opiate antagonists","volume":"86","author":"Bergasa","year":"1991","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0016-5085(92)90102-5","article-title":"A controlled trial of naloxone infusions for the pruritus of chronic cholestasis","volume":"102","author":"Bergasa","year":"1992","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-123-3-199508010-00001","article-title":"Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial","volume":"123","author":"Bergasa","year":"1995","journal-title":"Annals of Internal Medicine"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD008320.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0190-9622(99)70117-9","article-title":"Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study","volume":"41","author":"Bergasa","year":"1999","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0190-9622(98)70159-8","article-title":"Efficacy of pentoxifylline in the treatment of pruritic papular eruption of HIV-infected persons","volume":"38","author":"Berman","year":"1998","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2007.01.007","article-title":"Treatment of pruritus with topically applied opiate receptor antagonist","volume":"56","author":"Bigliardi","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0091-6749(89)90021-3","article-title":"Double-blind, placebo-controlled study of nicergoline in the treatment of pruritus in patients receiving maintenance hemodialysis","volume":"83","author":"Bousquet","year":"1989","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0190-9622(92)70013-6","article-title":"Topical capsaicin for treatment of hemodialysis-related pruritus","volume":"26","author":"Breneman","year":"1992","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0114|cit114","first-page":"321","article-title":"Efficacy of topical hydrating and emollient lotion containing 10% urea ISDIN\u00ae plus dexpanthenol (Ureadin Rx 10) in the treatment of skin xerosis and pruritus in hemodialyzed patients: an open prospective pilot trial","volume":"46","author":"Castello","year":"2011","journal-title":"Giornale Italiano Di Dermatologia e Venereologia [Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases]"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2006.03.082","article-title":"Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus","volume":"48","author":"Chen","year":"2006","journal-title":"American Journal of Kidney Diseases"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0016-5085(66)80071-9","article-title":"Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis","volume":"50","author":"Datta","year":"1966","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0885-3924(02)00645-0","article-title":"Mirtazapine for pruritus","volume":"25","author":"Davis","year":"2003","journal-title":"Journal of Pain and Symptom Management"},{"issue":"20","key":"10.1002\/14651858.CD008320.pub4-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM197811162992015","article-title":"Cimetidine treatment of pruritus in polycythemia vera","volume":"299","author":"Easton","year":"1978","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2340\/0001555559505512","article-title":"Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement","volume":"59","author":"Fjellner","year":"1979","journal-title":"Acta Dermato-Venereologica"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000188582","article-title":"Oral activated charcoal in patients with uremic pruritus","volume":"70","author":"Giovannetti","year":"1995","journal-title":"Nephron"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000045371","article-title":"Uremic pruritus: an unresolved problem in hemodialysis patients","volume":"82","author":"Goicoechea","year":"1999","journal-title":"Nephron"},{"issue":"7","key":"10.1002\/14651858.CD008320.pub4-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/1049909110362523","article-title":"Thalidomide for the control of severe paraneoplastic pruritus associated with Hodgkin's disease","volume":"27","author":"Goncalves","year":"2010","journal-title":"American Journal of Hospice & Palliative Medicine"},{"issue":"10074","key":"10.1002\/14651858.CD008320.pub4-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0140-6736(17)30319-7","article-title":"Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study","volume":"389","author":"Hegade","year":"2017","journal-title":"Lancet"},{"issue":"7279","key":"10.1002\/14651858.CD008320.pub4-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(63)92362-6","article-title":"A comparative trial of trimeprazine and amylobarbitone in pruritus","volume":"1","author":"Hellier","year":"1963","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1089\/jpm.2005.8.1290","article-title":"Treatment of pruritus caused by cholestasis with opioid antagonists","volume":"8","author":"Jones","year":"2005","journal-title":"Journal of Palliative Medicine"},{"issue":"76","key":"10.1002\/14651858.CD008320.pub4-BIB0126|cit126","first-page":"1196","article-title":"Ondansetron and pruritus in chronic liver disease: a controlled study","volume":"54","author":"Jones","year":"2007","journal-title":"Hepato-Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0127|cit127","first-page":"331","article-title":"Buprenorphine and hepatic pruritus","volume":"48","author":"Juby","year":"1994","journal-title":"British Journal of Clinical Practice"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1525-1594.2001.025006441.x","article-title":"Polymethylmethacrylate efficacy in reduction of renal itching in hemodialysis patients: crossover study and role of tumor necrosis factor-alpha","volume":"25","author":"Kato","year":"2001","journal-title":"Artificial Organs"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jpainsymman.2008.01.004","article-title":"Carbamazepine can be effective in alleviating tormenting pruritus in patients with hematologic malignancy","volume":"35","author":"Korfitis","year":"2008","journal-title":"Journal of Pain and Symptom Management"},{"issue":"7","key":"10.1002\/14651858.CD008320.pub4-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/ndt\/gfh202","article-title":"A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy","volume":"19","author":"Kuypers","year":"2004","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD008320.pub4-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/gut.52.9.1323","article-title":"Topical capsaicin - a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study","volume":"52","author":"Lysy","year":"2003","journal-title":"Gut"},{"issue":"7","key":"10.1002\/14651858.CD008320.pub4-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3748\/wjg.v12.i7.1125","article-title":"Effect of oral naltrexone on pruritus in cholestatic patients","volume":"12","author":"Mansour-Ghanaei","year":"2006","journal-title":"World Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1590\/S0101-28002012000200007","article-title":"Uremic pruritus in hemodialysis patients: treatment with desloratidine versus gabapentin","volume":"34","author":"Marquez","year":"2012","journal-title":"Jornal Brasileiro Nefrologia"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0134|cit134","first-page":"533","article-title":"Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases","volume":"41","author":"Metze","year":"1999","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD008320.pub4-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.transproceed.2006.08.052","article-title":"Treatment of refractory cholestatic pruritus with molecular adsorbent recirculating system (MARS)","volume":"38","author":"Montero","year":"2006","journal-title":"Transplantation Proceedings"},{"issue":"10","key":"10.1002\/14651858.CD008320.pub4-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00042737-199810000-00010","article-title":"Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial","volume":"10","author":"M\u00fcller","year":"1998","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00042737-199810000-00010","article-title":"Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial","volume":"10","author":"M\u00fcller","year":"1998","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40620-014-0039-2","article-title":"Effects of turmeric on uremic pruritus in end stage renal disease patients: a double-blind randomized clinical trial","volume":"27","author":"Pakfetrat","year":"2014","journal-title":"Journal of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF01300759","article-title":"Treatment of pruritus of primary biliary cirrhosis with rifampin","volume":"36","author":"Podesta","year":"1991","journal-title":"Digestive Diseases and Sciences"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s005200050210","article-title":"Rifampicin as treatment for pruritus in malignant cholestasis","volume":"6","author":"Price","year":"1998","journal-title":"Supportive Care in Cancer"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jpainsymman.2004.10.001","article-title":"The use of midazolam to treat itching in a terminally ill patient with biliary obstruction","volume":"28","author":"Prieto","year":"2004","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/08860220802595476","article-title":"Gabapentin and uremic pruritus in hemodialysis patients","volume":"31","author":"Razeghi","year":"2009","journal-title":"Renal Failure"},{"issue":"31","key":"10.1002\/14651858.CD008320.pub4-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"e10764","DOI":"10.1097\/MD.0000000000010764","article-title":"A randomized controlled trial for effectiveness of zolpidem versus acupressure on sleep in hemodialysis patients having chronic kidney disease-associated pruritus.","volume":"97","author":"Rehman","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ajg.2017.287","article-title":"Effects of bezafibrate on outcome and pruritus in primary biliary cholangitis with suboptimal ursodeoxycholic acid response","volume":"113","author":"Reig","year":"2018","journal-title":"American Journal of Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD008320.pub4-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1080\/00365520600610154","article-title":"Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus \u00ae)","volume":"41","author":"Rifai","year":"2006","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"40","key":"10.1002\/14651858.CD008320.pub4-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000508288","article-title":"The effect of ostrich oil as a complementary medicine on the severity of pruritus and quality of life in hemodialysis patients","volume":"28","author":"Sadeghnejad","year":"2021","journal-title":"Complementary Medicine Research"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jpainsymman.2012.03.001","article-title":"Use of pregabalin in the management of chronic uremic pruritus","volume":"45","author":"Shavit","year":"2013","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2340\/00015555-0553","article-title":"Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study","volume":"89","author":"St\u00e4nder","year":"2009","journal-title":"Acta Dermato-Venereologica"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0149|cit149","first-page":"97","article-title":"Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study","volume":"13","author":"Szepietowski","year":"2005","journal-title":"Acta Dermatovenerologica Croatica"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0150|cit150","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/09546639009086741","article-title":"A randomized, crossover trial of Sarna and Eurax lotions in the treatment of haemodialysis patients with uraemic pruritus","volume":"1","author":"Tan","year":"1990","journal-title":"Journal of Dermatological Treatment"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0151|cit151","first-page":"93","article-title":"Effects of oral granisetron treatment on uremic pruritus","volume":"35","author":"Tokg\u00f6z","year":"2005","journal-title":"Turkish Journal of Medical Sciences"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00004836-199004000-00012","article-title":"Failure of rifampin to relieve pruritus in chronic liver disease","volume":"12","author":"Woolf","year":"1990","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000045271","article-title":"Effects of oral supplementation with evening primrose oil for six weeks on plasma essential fatty acids and uremic skin symptoms in hemodialysis patients","volume":"81","author":"Yoshimoto-Furuie","year":"1999","journal-title":"Nephron"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0154|cit154","unstructured":"Pregabalin for the treatment of uremic pruritus clinicaltrials.gov\/ct2\/show\/NCT01852318"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0155|cit155","unstructured":"Efficacy of calmmax cream in the management of chronic uremic pruritus clinicaltrials.gov\/ct2\/show\/NCT02032537"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0156|cit156","unstructured":"Safety and pharmacokinetics of iv CR845 in hemodialysis patients, and Its efficacy in patients with uremic pruritus clinicaltrials.gov\/ct2\/show\/NCT02229929"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0157|cit157","unstructured":"Treatment of uremic pruritus with PA101B clinicaltrials.gov\/ct2\/show\/NCT02696499"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0158|cit158","unstructured":"The effect of bezafibrate on cholestatic itch (FITCH) clinicaltrials.gov\/ct2\/show\/NCT02701166"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0159|cit159","unstructured":"Naloxone hydrochloride study for relief of pruritus in patients with MF or SS forms of CTCL clinicaltrials.gov\/ct2\/show\/NCT02811783"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0160|cit160","unstructured":"MRX-502: Randomized double-blind placebo-controlled phase 3 study to evaluate the efficacy and safety of maralixibat in the treatment of subjects with progressive familial intrahepatic cholestasis (PFIC) - MARCH-PFIC clinicaltrials.gov\/ct2\/show\/NCT03905330"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0161|cit161","unstructured":"Study to evaluate the safety and efficacy of oral CR845 (difelikefalin) in patients with primary biliary cholangitis (PBC) and moderate-to-severe pruritus clinicaltrials.gov\/ct2\/show\/NCT03995212"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0162|cit162","unstructured":"A study evaluating the safety, pharmacokinetics, and efficacy of HSK21542 injection in subjects undergoing hemodialysis clinicaltrials.gov\/ct2\/show\/NCT04470154"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0163|cit163","unstructured":"Narrow band UVB phototherapy versus pregabalin in treatment of refractory pruritus in ESRD clinicaltrials.gov\/ct2\/show\/NCT04660773"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0164|cit164","unstructured":"A study to evaluate efficacy and safety of an investigational drug named volixibat in patients with itching caused by primary sclerosing cholangitis (VISTAS) clinicaltrials.gov\/ct2\/show\/NCT04663308"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0165|cit165","unstructured":"A mlti-site bridging study of nalfurafine hydrochloride orally disintegrating tablet clinicaltrials.gov\/ct2\/show\/NCT04728984"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0166|cit166","unstructured":"Global linerixibat itch study of efficacy and safety in primary biliary cholangitis (PBC) (GLISTEN) clinicaltrials.gov\/ct2\/show\/NCT04950127"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0167|cit167","unstructured":"A clinical trial evaluating the efficacy, safety, and pharmacokinetics of HSK21542 injection in liver disease subjects with pruritus clinicaltrials.gov\/ct2\/show\/NCT04999787"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0168|cit168","unstructured":"To evaluate the efficacy and safety of nemolizumab for 12 weeks in participants with chronic kidney disease with associated severe pruritus (Nemo CKDaP) clinicaltrials.gov\/ct2\/show\/NCT05075408"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0169|cit169","unstructured":"DIalysis Symptom COntrol-Pruritus Outcome Trial (DISCO-POT) clinicaltrials.gov\/ct2\/show\/NCT05180968"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0170|cit170","unstructured":"Sertraline effect in uremic pruritis clinicaltrials.gov\/ct2\/show\/NCT05341843"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0171|cit171","unstructured":"A study to evaluate the safety and efficacy of difelikefalin in advanced chronic kidney disease patients with moderate-to-severe pruritus and not on dialysis clinicaltrials.gov\/ct2\/show\/NCT05342623"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0172|cit172","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jaad.2011.12.021","article-title":"Pruritus in cutaneous T-cell lymphoma: a review","volume":"67","author":"Ahern","year":"2012","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0173|cit173","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/1049909112445464","article-title":"Gabapentin for pruritus in palliative care","volume":"30","author":"Anand","year":"2013","journal-title":"American Journal of Hospice & Palliative Care"},{"issue":"Issue 1","key":"10.1002\/14651858.CD008320.pub4-BIB0174|cit174","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013128.pub2","article-title":"Interventions for chronic pruritus of unknown origin\u00a0","author":"Andrade","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0175|cit175","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000183485","article-title":"Cutaneous abnormalities in uremic patients","volume":"40","author":"Bencini","year":"1985","journal-title":"Nephron"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0176|cit176","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.cld.2008.02.01","article-title":"Pruritus in primary biliary cirrhosis: pathogenesis and therapy","volume":"12","author":"Bergasa","year":"2008","journal-title":"Clinics in Liver Disease"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0177|cit177","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1529-8019.2005.00040.x","article-title":"Itch and pruritus: what are they, and how should itches be classified?","volume":"18","author":"Bernhard","year":"2005","journal-title":"Dermatologic Therapy"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0178|cit178","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007303.pub2","article-title":"Erythropoietin or darbepoetin for patients with cancer - meta-analysis based on individual patient data","author":"Bohlius","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0179|cit179","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.sder.2011.05.003","article-title":"Cancer and itch","volume":"30","author":"Chaing","year":"2011","journal-title":"Seminars in Cutaneous Medicine and Surgery"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0180|cit180","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"9","key":"10.1002\/14651858.CD008320.pub4-BIB0181|cit181","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010111","article-title":"Topical capsaicin (low concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0182|cit182","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007393.pub4","article-title":"Topical capsaicin (high concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0183|cit183","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jaad.2008.04.006","article-title":"A pilot quality-of-life instrument for pruritus","volume":"59","author":"Desai","year":"2008\u00a0","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD008320.pub4-BIB0184|cit184","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000025.pub2","article-title":"Magnesium sulphate and other anticonvulsants for women with pre-eclampsia","author":"Duley","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD008320.pub4-BIB0185|cit185","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11894-019-0713-6","article-title":"Treatment of pruritus secondary to liver disease","volume":"21","author":"D\u00fcll","year":"2019\u00a0","journal-title":"Liver"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0186|cit186","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000184487","article-title":"Electrical needle therapy of uremic pruritus","volume":"47","author":"Duo","year":"1987","journal-title":"Nephron"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0187|cit187","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: Management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009\u00a0","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0188|cit188","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.sder.2011.04.008","article-title":"Topical therapies for pruritus","volume":"30","author":"Elmariah","year":"2011","journal-title":"Seminars in Cutaneous Medicine and Surgery"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0189|cit189","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/ijd.14708","article-title":"Gabapentin for uremic pruritus: a systematic review of randomized controlled trials","volume":"59","author":"Eusebio-Alpapara","year":"2020\u00a0","journal-title":"Internation Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0190|cit190","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994\u00a0","journal-title":"Clinical and Experimental Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0191|cit191","first-page":"310","article-title":"Treatment of pruritus","volume":"7","author":"Fransway","year":"1988","journal-title":"Seminars in Dermatology"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0192|cit192","first-page":"277","volume-title":"Pruritus","author":"Gaudy-Marqueste","year":"2010"},{"issue":"8","key":"10.1002\/14651858.CD008320.pub4-BIB0193|cit193","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/j.1365-4632.2010.04537.x","article-title":"Systematic review of topical capsaicin in the treatment of pruritus","volume":"49","author":"Gooding","year":"2010","journal-title":"International Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0194|cit194","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002022.pub3","article-title":"Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal","author":"Gowing","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0195|cit195","unstructured":"GRADEproGDT GRADE Working Group, McMaster University 2015"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0196|cit196","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables - binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0197|cit197","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles - continuous outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0198|cit198","first-page":"98","volume-title":"On Pruritis\u00a0","author":"Haffenreffer","year":"1660"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0199|cit199","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0200|cit200","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004223.pub2","article-title":"Topically applied anaesthetics for treating perineal pain after childbirth","author":"Hedayati","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD008320.pub4-BIB0201|cit201","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011393.pub2","article-title":"Interventions for itch in people with advanced chronic kidney disease","author":"Hercz","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD008320.pub4-BIB0202|cit202","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0203|cit203","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0204|cit204","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane 2021 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0205|cit205","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0885-3924(97)00006-7","article-title":"A multicenter evaluation of cancer pain control by palliative care teams","volume":"14","author":"Higginson","year":"1997","journal-title":"Journal of Pain and Symptom Management"},{"issue":"7","key":"10.1002\/14651858.CD008320.pub4-BIB0206|cit206","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrn1950","article-title":"The neurobiology of itch","volume":"7","author":"Ikoma","year":"2006","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0207|cit207","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/CCID.S55942","article-title":"Nalfurafine hydrochloride to treat pruritus: a review","volume":"8","author":"Inui","year":"2015","journal-title":"Clinical Cosmetic and Investigational Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD008320.pub4-BIB0208|cit208","doi-asserted-by":"publisher","first-page":"1622\u20139","DOI":"10.1136\/gut.2005.065862","article-title":"Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis","volume":"54","author":"Jacoby","year":"2005","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0209|cit209","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/hep.51029045","article-title":"The pruritus of cholestasis","volume":"29","author":"Jones","year":"1999","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0210|cit210","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/s0190-9622(83)70144-1","article-title":"Generalized pruritus and systemic disease","volume":"9","author":"Kantor","year":"1983","journal-title":"Journal of American Medical Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0211|cit211","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02090052","article-title":"Pruritus associated with cholestasis. A review of pathogenesis and management","volume":"39","author":"Khandelwal","year":"1994","journal-title":"Digestive Diseases and Sciences"},{"issue":"8","key":"10.1002\/14651858.CD008320.pub4-BIB0212|cit212","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1478-3231.2006.01326.x","article-title":"Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials","volume":"26","author":"Khurana","year":"2006","journal-title":"Liver International"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0213|cit213","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0885-3924(00)00256-6","article-title":"Understanding pruritus in systemic disease","volume":"21","author":"Krajnik","year":"2001","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0300-2977(00)00084-X","article-title":"Pruritus in advanced internal diseases. Pathogenesis and treatment","volume":"58","author":"Krajnik","year":"2001","journal-title":"Netherlands Journal of Medicine"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0215|cit215","doi-asserted-by":"publisher","first-page":"157\u201370","DOI":"10.1038\/ncpneph1040","article-title":"Skin problems in chronic kidney disease","volume":"5","author":"Kuypers","year":"2009","journal-title":"Nature Reviews Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0216|cit216","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2230.2009.03218","article-title":"Pruritus measurement and treatment","volume":"34","author":"Langner","year":"2009","journal-title":"Clinical and Experimental Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/j.1875-9114.1996.tb03015.x","article-title":"Treatment of opioid-induced pruritus with ondansetron: report of four patients","volume":"16","author":"Larijani","year":"1996","journal-title":"Pharmacotherapy"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD008320.pub4-BIB0218|cit218","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/s0190-9622(88)80248-","article-title":"Should the patient with generalized pruritus be evaluated for malignancy?","volume":"19","author":"Lober","year":"1988","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0219|cit219","first-page":"231","article-title":"Some statistical methods for use in assessing the adequacy of hemodialysis","volume":"2","author":"Lowrie","year":"1975","journal-title":"Kidney International Supplement"},{"issue":"10","key":"10.1002\/14651858.CD008320.pub4-BIB0220|cit220","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.2215\/CJN.01610214","article-title":"Setting research priorities for patients on or nearing dialysis","volume":"9","author":"Manns","year":"2014","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD008320.pub4-BIB0221|cit221","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.2215\/CJN.00100110","article-title":"A longitudinal study of uremic pruritus in hemodialysis patients","volume":"5","author":"Mathur","year":"2010","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0222|cit222","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1365-2249.1995.tb05527.x","article-title":"The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures","volume":"99","author":"McHugh","year":"1995","journal-title":"Clinical & Experimental Immunology"},{"issue":"7","key":"10.1002\/14651858.CD008320.pub4-BIB0223|cit223","doi-asserted-by":"publisher","first-page":"857\u201370","DOI":"10.1046\/j.1365-2036.2003.01458.x","article-title":"Review article: pruritus in cholestatic and other liver diseases","volume":"17","author":"Mela","year":"2003","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0224|cit224","doi-asserted-by":"publisher","first-page":"467\u201374","DOI":"10.1111\/j.1365-2133.1986.tb06241.x","article-title":"Behavioural treatment of scratching in patients with atopic dermatitis","volume":"115","author":"Melin","year":"1986","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0225|cit225","first-page":"136","article-title":"Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD): the role of plasma histamine and skin mast cells","volume":"34","author":"Mettang","year":"1990","journal-title":"Clinical Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD008320.pub4-BIB0226|cit226","doi-asserted-by":"publisher","first-page":"1558\u201363","DOI":"10.1093\/ndt\/17.9.1558","article-title":"Uraemic pruritus \u2013 new perspectives and insights from recent trials","volume":"17","author":"Mettang","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0227|cit227","first-page":"167","volume-title":"Pruritus","author":"Mettang","year":"2010"},{"issue":"11","key":"10.1002\/14651858.CD008320.pub4-BIB0228|cit228","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/j.1468-3083.2010.03850.x","article-title":"Chronic pruritus - pathogenesis, clinical aspects and treatment","volume":"24","author":"Metz","year":"2010","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0229|cit229","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1749-6632.1999.tb08705.x","article-title":"Effective treatment of pruritus with naltrexone, an orally active opiate antagonist","volume":"885","author":"Metze","year":"1999","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0230|cit230","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-84882-322-8","volume-title":"Pruritus","author":"Misery","year":"2010"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0231|cit231","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub3","article-title":"Pregabalin for acute and chronic pain in adults","author":"Derry","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-1-84882-322-8_48","volume-title":"Pruritus","author":"Moretti","year":"2010"},{"issue":"11","key":"10.1002\/14651858.CD008320.pub4-BIB0233|cit233","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006271.pub3","article-title":"Haloperidol for the treatment of nausea and vomiting in palliative care patients","author":"Murray-Brown","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0234|cit234","doi-asserted-by":"publisher","first-page":"509","DOI":"10.15171\/apb.2016.064","article-title":"Therapeutic effects of omega-3 fatty acids on chronic kidney disease-associated pruritus: a literature review","volume":"6","author":"Panahi","year":"2016","journal-title":"Advanced Pharmaceutical Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0235|cit235","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jaad.2009.08.052","article-title":"Antipruritic treatment with systemic \u03bc-opioid receptor antagonists: a review","volume":"63","author":"Phan","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD008320.pub4-BIB0236|cit236","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1093\/ndt\/gfl461","article-title":"Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"21","author":"Pisoni","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0237|cit237","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1191\/0269216303pm760oa","article-title":"Symptoms in 400 patients referred to palliative care services: prevalence and patterns","volume":"17","author":"Potter","year":"2003","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-84882-322-8_19","volume-title":"Pruritus","author":"Proske","year":"2010"},{"issue":"7","key":"10.1002\/14651858.CD008320.pub4-BIB0239|cit239","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00105-011-2320-9","article-title":"Antidepressant drugs: a reasonable therapy for pruritus?","volume":"63","author":"Raap","year":"2012","journal-title":"Der Hautarzt"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0240|cit240","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004893.pub3","article-title":"Anticonvulsants for preventing seizures in patients with chronic subdural haematoma","author":"Ratilal","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2340\/00015555-1265","article-title":"Visual analogue scale: Evaluation of the Instrument for the assessment of pruritus","volume":"92","author":"Reich","year":"2012","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0242|cit242","unstructured":"Review Manager (RevMan) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0243|cit243","unstructured":"RevManWeb Cochrane 2021 https:\/\/revman.cochrane.org"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0244|cit244","unstructured":"R: A language and environment for statistical computing R Core Team R Foundation for Statistical Computing 2021"},{"issue":"12","key":"10.1002\/14651858.CD008320.pub4-BIB0245|cit245","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001867.pub3","article-title":"Opioid antagonists for alcohol dependence","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"26","key":"10.1002\/14651858.CD008320.pub4-BIB0246|cit246","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1017\/s0033291700035558","article-title":"The Inventory of Depressive Symptomatology (IDS): psychometric properties","volume":"May","author":"Rush","year":"1996","journal-title":"Psychological Medicine"},{"issue":"20","key":"10.1002\/14651858.CD008320.pub4-BIB0247|cit247","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1523\/JNEUROSCI.17-20-08003.1997","article-title":"Specific C-receptors for itch in human skin","volume":"17","author":"Schmelz","year":"1997","journal-title":"Journal of Neuroscience"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0248|cit248","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G GRADE handbook for grading quality of evidence and strength of recommendations (updated October 2013). The GRADE Working Group, 2013 Available from guidelinedevelopment.org\/handbook"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0249|cit249","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-21416-0","volume-title":"Meta-Analysis with R","author":"Schwarzer","year":"2015"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0250|cit250","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0304-3959(94)00145-","article-title":"Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron","volume":"61","author":"Schworer","year":"1995","journal-title":"Pain"},{"issue":"9","key":"10.1002\/14651858.CD008320.pub4-BIB0251|cit251","first-page":"1010","article-title":"Pruritus in palliative care","volume":"57","author":"Seccareccia","year":"2011","journal-title":"Canadian Family Physician"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0252|cit252","first-page":"148","volume-title":"Cancer Symptom Management","author":"Seiz","year":"1999"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0253|cit253","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/s0022-3476(67)80212-9","article-title":"Cholestyramine therapy in patients with a paucity of intrahepatic bile ducts","volume":"71","author":"Sharp","year":"1967","journal-title":"Journal of Pediatrics"},{"issue":"50","key":"10.1002\/14651858.CD008320.pub4-BIB0254|cit254","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3238\/arztebl.2014.0863","article-title":"Drug treatments for pruritus in adult palliative care","volume":"111","author":"Siemens","year":"2014","journal-title":"Deutsches \u00c4rzteblatt International"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0255|cit255","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/j.ajkd.2017.05.018","article-title":"Treatment of uremic pruritus: a systematic review","volume":"70","author":"Simonsen","year":"2017\u00a0","journal-title":"American Journal of Kidney Disease"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0256|cit256","first-page":"633","article-title":"Doxepin in the management of pruritus associated with allergic cutaneous reactions","volume":"31","author":"Smith","year":"1997","journal-title":"Annals of Pharmacotherapy"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0257|cit257","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1600-0625.2007.00664.","article-title":"Neurophysiological and neurochemical basis of modern pruritus treatment","volume":"17","author":"St\u00e4nder","year":"2008","journal-title":"Experimental Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD008320.pub4-BIB0258|cit258","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/sj.jid.570023","article-title":"Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus","volume":"126","author":"Steinhoff","year":"2006","journal-title":"Journal of Investigative Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0259|cit259","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.sder.2011.05.001","article-title":"Pruritus: management algorithms and experimental therapies","volume":"30","author":"Steinhoff","year":"2011","journal-title":"Seminars in Cutaneous Medicine and Surgery"},{"issue":"11","key":"10.1002\/14651858.CD008320.pub4-BIB0260|cit260","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006938.pub3","article-title":"Droperidol for treatment of nausea and vomiting in palliative care patients","author":"Storrar","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0261|cit261","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-3-54","article-title":"Study flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagram","volume":"3","author":"Stovold","year":"2014","journal-title":"Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0262|cit262","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1529-8019.2005.00035.x","article-title":"Pharmacologic advances in the systemic treatment of itch","volume":"18","author":"Summey","year":"2005","journal-title":"Dermatologic Therapy"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0263|cit263","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/B978-0-323-05674-8.50170-5","volume-title":"Palliative Medicine","author":"Summey","year":"2009"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0264|cit264","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1056\/NEJM199408113310606","article-title":"Renal transplantation","volume":"331","author":"Suthanthiran","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0265|cit265","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jaad.2004.04.00","article-title":"Pruritus: still an important clinical problem","volume":"51","author":"Szepietowski","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD008320.pub4-BIB0266|cit266","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1111\/j.1572-0241.2007.01200.x","article-title":"The efficacy and safety of bile acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus","volume":"102","author":"Tandon","year":"2007","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0267|cit267","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/s0733-8635(05)70239-4","article-title":"Neurotropic and psychotropic drugs in dermatology","volume":"19","author":"Tennyson","year":"2001","journal-title":"Dermatologic Clinics"},{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD008320.pub4-BIB0268|cit268","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/01.mcg.0000155551.37266.26","article-title":"Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis","volume":"39","author":"Trauner","year":"2005","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0269|cit269","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.pain.2008.06.025","article-title":"Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations","volume":"139","author":"Turk","year":"2008","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0270|cit270","first-page":"415","article-title":"Flumecinol is a powerful inducer of bilirubin conjugation in Gilbert\u2019s syndrome [Abstract]","volume":"12","author":"Turner","year":"1990","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0271|cit271","volume-title":"Symptom Management in Advanced Cancer","author":"Twycross","year":"2001"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/acprof:oso\/9780198525103.003.0015","volume-title":"Pruritus in Advanced Disease","author":"Twycross","year":"2004"},{"issue":"11","key":"10.1002\/14651858.CD008320.pub4-BIB0273|cit273","doi-asserted-by":"publisher","first-page":"823","DOI":"10.5414\/CP201852","article-title":"One year long-term study on abuse liability of nalfurafine in hemodialysis patients","volume":"51","author":"Ueno","year":"2013","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0274|cit274","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1365-2133.1997.tb03793.","article-title":"The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression","volume":"137","author":"Uthayakumar","year":"1997","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-84882-322-8_8","volume-title":"Pruritus","author":"Wallengren","year":"2010"},{"issue":"3","key":"10.1002\/14651858.CD008320.pub4-BIB0276|cit276","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s005200050281","article-title":"The symptoms of advanced cancer: relationship to age, gender, and performance status in 1000 patients","volume":"8","author":"Walsh","year":"2000","journal-title":"Supportive Care in Cancer"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0277|cit277","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-4632.2009.04249.","article-title":"New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma","volume":"49","author":"Wang","year":"2010","journal-title":"International Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0278|cit278","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006100.pub2","article-title":"Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children","author":"Watts","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0279|cit279","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003961.pub2","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients","author":"Webster","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0280|cit280","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-684X-7-13","article-title":"How useful are systematic reviews for informing palliative care practice? Survey of 25 Cochrane systematic reviews","volume":"7","author":"Wee","year":"2008","journal-title":"BMC Palliative Care"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0281|cit281","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/00015555-0369","article-title":"Pruritus - a review","volume":"213","author":"Weisshaar","year":"2003","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0282|cit282","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2340\/00015555-0662","article-title":"Epidemilogy of itch: adding the burden of skin morbidity","volume":"89","author":"Weisshaar","year":"2009","journal-title":"Acta Dermato-Venereologica"},{"issue":"4","key":"10.1002\/14651858.CD008320.pub4-BIB0283|cit283","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005451.pub3","article-title":"Carbamazepine for acute and chronic pain in adults","author":"Wiffen","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0284|cit284","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2165\/00003495-199652050-00010","article-title":"Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications","volume":"52","author":"Wilde","year":"1996","journal-title":"Drugs"},{"issue":"9","key":"10.1002\/14651858.CD008320.pub4-BIB0285|cit285","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2165\/00044011-200828090-00001","article-title":"Therapeutic use of nicergoline","volume":"28","author":"Winblad","year":"2008","journal-title":"Clinical Drug Investigation"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0286|cit286","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1146\/annurev.me.15.020164.000413","article-title":"Pruritus","volume":"15","author":"Winkelmann","year":"1964","journal-title":"Annual Review of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0287|cit287","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/s0025-7125(16)31386-4","article-title":"Pharmacologic control of pruritus","volume":"66","author":"Winkelmann","year":"1982","journal-title":"Medical Clinics of North America"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0288|cit288","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s0168-0102(99)00070-x","article-title":"Itch-associated response induced by intradermal serotonin through 5-HT2 receptors in mice","volume":"35","author":"Yamaguchi","year":"1999","journal-title":"Neuroscience Research"},{"issue":"5831","key":"10.1002\/14651858.CD008320.pub4-BIB0289|cit289","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/bmj.4.5831.51","article-title":"Activated charcoal rediscovered","volume":"4","author":"Yatzidis","year":"1972","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0290|cit290","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1527-3458.2001.tb00195.x","article-title":"Ondansetron: a selective 5-HT(3) receptor antagonist and its applications in CNS-related disorders","volume":"7","author":"Ye","year":"2001","journal-title":"CNS Drug Review"},{"issue":"9358","key":"10.1002\/14651858.CD008320.pub4-BIB0291|cit291","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S0140-6736(03)12570-6","article-title":"Itch","volume":"361","author":"Yosipovitch","year":"2003","journal-title":"Lancet"},{"issue":"17","key":"10.1002\/14651858.CD008320.pub4-BIB0292|cit292","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMcp1208814","article-title":"Clinical practice. Chronic pruritus","volume":"368","author":"Yosipovitch","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0293|cit293","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983\u00a0","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"7211","key":"10.1002\/14651858.CD008320.pub4-BIB0294|cit294","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1136\/bmj.319.7211.693","article-title":"What is complementary medicine?","volume":"319","author":"Zollman","year":"1999","journal-title":"British Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD008320.pub4-BIB0295|cit295","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/s0190-9622(03)02478-2","article-title":"Relevance and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease","volume":"49","author":"Zucker","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD008320.pub4-BIB0296|cit296","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s0885-3924(98)00048-7","article-title":"Paroxetine for pruritus in advanced cancer","volume":"16","author":"Zylicz","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD008320.pub4-BIB0297|cit297","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780198525103.001.0001","volume-title":"Pruritus in Advanced Disease","author":"Zylicz","year":"2004"},{"issue":"11","key":"10.1002\/14651858.CD008320.pub4-BIB0298|cit298","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008320.pub3","article-title":"Pharmacological interventions for pruritus in adult palliative care patients","author":"Siemens","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD008320.pub4-BIB0299|cit299","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008320","article-title":"Pharmacological interventions for pruritus in adult palliative care patients (protocol)","author":"Xander","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD008320.pub4-BIB0300|cit300","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008320.pub2","article-title":"Pharmacological interventions for pruritus in adult palliative care patients","author":"Xander","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T22:49:54Z","timestamp":1758581394000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008320.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":300,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008320.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]}}}